The influence of fixed and free final time of treatment on optimal chemotherapeutic protocols
From MaRDI portal
(Redirected from Publication:1388959)
Recommendations
- Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach
- Two optimal control problems in cancer chemotherapy with drug resistance
- Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies
- The influence of PK/PD on the structure of optimal controls in cancer chemotherapy models
- Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
Cites work
- scientific article; zbMATH DE number 639801 (Why is no real title available?)
- scientific article; zbMATH DE number 672044 (Why is no real title available?)
- scientific article; zbMATH DE number 219851 (Why is no real title available?)
- scientific article; zbMATH DE number 3256013 (Why is no real title available?)
- scientific article; zbMATH DE number 3297399 (Why is no real title available?)
- scientific article; zbMATH DE number 3306310 (Why is no real title available?)
- Chemotherapeutic treatments involving drug resistance and level of normal cells as a criterion of toxicity
- Drug kinetics and drug resistance in optimal chemotherapy
- Optimal control analysis in the chemotherapy of IgG multiple myeloma
- Role of optimal control theory in cancer chemotherapy
- Singularity of optimal control in some problems related to optimal chemotherapy
This page was built for publication: The influence of fixed and free final time of treatment on optimal chemotherapeutic protocols
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q1388959)